Washington — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.
Earlier this month, the company launched its first DNA-encoded library of its proprietary macromolecules, which it hopes will ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
Hungry New Mexicans from near and far followed the scent of roasted red chile and chicharrónes to Belen for the World's ...
The Food and Drug Administration’s approval of low-risk tobacco pouches is welcome, but why did it delay for more than four ...
Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive ...
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...
Prince Harry's visa status in the US faces scrutiny under the Trump administration. Judge Carl J. Nichols has ordered court hearings over allegations ...
The approval is for the Abbreviated New Drug Application (ANDA) for Everolimus tablets for oral suspension (TFOS) of ...